54 Trending Stocks

Tue, Jan 26, 2021

NantKwest Inc

NK 19.01
1.76 (10.2%)

Open: 17.31 High: 19.07 Low: 16.95

9 x 19.01 = 171.09
x $19.01 =

NASDAQ: NK $2 Million Small-Cap. New 52 WEEK HIGH Tuesday. Health Care Sector. Biotech & Pharma Industry. 5 Year Return 76%. 1 Year Return 208%. 2021 YTD Return 38%. Since Earnings 134%.

ST

External Links

Charts

image
image

52WL $2.52

The 52 Week Low is $2.52 set on Fri, Apr 3, 2020.

52WH $19.07

The 52 Week High is $19.07 set on Mon, Jan 25, 2021.

ATH $37.50

The All-Time High is $37.50 set on Wed, Jul 29, 2015.

52 Week Range

$2.52
$19.07
Apr 3, 2020
Jan 25, 2021

Earnings

-0.20

Earnings Per Share

0.00

Price To Earnings Ratio


Q2 Earnings for Apr, May & Jun

Fri, Aug 7, 2020

Since Q2 Earnings Report

NK 80.9%


Q3 Earnings for Jul, Aug & Sep

Mon, Nov 9, 2020

Since Q3 Earnings Report

NK 134.4%

Dividends

0.00

Dividend Yield

0.00

Dividend Rate

--

Ex-Dividend Date

--

Dividend Payment Date

--

Dividend Frequency

0

Dividend History

Profile

NantKwest Inc trades on the NASDAQ. NK's market cap is 1.9 Billion.

NantKwest Inc is a United States-based firm functioning in the healthcare sector. It is focused on providing immunotherapeutic agents, especially natural killer cells to treat cancer, infectious and inflammatory diseases. Natural Killer (NK) cells are ancient cells in the human body designed to recognize and detect cells under stress or infected. The company's drug candidates such as activated NK cells, high-affinity NKs and target activated NK's address virally-induced cancers, viral, fungal and bacterial infections as well as critical diseases such as Ebola. Its pipeline product includes taNK, haNK, and aNK. Most of NatWest's sales are concentrated in the United States region although it has a reasonable market in Europe and other Non-U.S. territories.

Website

Related Channels

Free Channels & more...

For Starters

Account Channels

Track your portfolio and more.